Skip to main content

Fulgent Genetics, Inc. (FLGT)

NASDAQ: FLGT · IEX Real-Time Price · USD
78.14
+0.12 (0.15%)
After-hours:Oct 15, 2021 7:59 PM EDT
78.02
-0.65 (-0.83%)
At close: Oct 15, 4:00 PM
Market Cap2.32B
Revenue (ttm)909.74M
Net Income (ttm)493.45M
Shares Out29.15M
EPS (ttm)17.59
PE Ratio4.44
Forward PE20.92
Dividendn/a
Ex-Dividend Daten/a
Volume680,274
Open79.58
Previous Close78.67
Day's Range75.66 - 80.08
52-Week Range30.05 - 189.89
Beta1.49
AnalystsHold
Price Target141.00 (+80.7%)
Est. Earnings DateNov 8, 2021

About FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States ...

IndustryHealth Care Providers & Services
IPO DateSep 29, 2016
CEOMing Hsieh
Employees626
Stock ExchangeNASDAQ
Ticker SymbolFLGT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for FLGT stock is "Hold." The 12-month stock price forecast is 141.00, which is an increase of 80.72% from the latest price.

Price Target
$141.00
(80.72% upside)
Analyst Consensus: Hold

News

3 Top Healthcare Stocks to Buy Right Now

Each has its own reason for being in your portfolio.

Other symbols:JNJRMD
3 days ago - The Motley Fool

Is FULGENT GENETIC (FLGT) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

4 days ago - Zacks Investment Research

What's Going on With Fulgent Genetics?

The company is leveraging success with its COVID-19 tests to position itself better for a post-pandemic world.

6 days ago - The Motley Fool

Where to Invest $5,000 Right Now

An investment in one or both of these high-growth companies could generate stellar returns.

Other symbols:GOOGGOOGL
1 week ago - The Motley Fool

Can This Stock Grow Despite a COVID Testing Decline?

Fulgent has capitalized on COVID-19 testing, but even though this segment of its business might slow, there are plenty of reasons to own the company.

Other symbols:NVTA
1 week ago - The Motley Fool

These 3 Top Healthcare Stocks Are Screaming Buys Right Now

If the market crashes these companies could be insulated.

Other symbols:BMYCRSP
2 weeks ago - The Motley Fool

Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19...

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in onc...

3 weeks ago - Business Wire

3 Unstoppable Healthcare Stocks to Buy With Just $1,000

It doesn't take much when you buy great companies and let them grow.

Other symbols:ISRGRGEN
3 weeks ago - The Motley Fool

The 1 Stock I'd Buy Right Now

The pandemic isn't over yet.

Other symbols:EXASGHILMN
4 weeks ago - The Motley Fool

3 Top Healthcare Stocks You Can Buy for $100 or Less

It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.

Other symbols:NARITDOC
1 month ago - The Motley Fool

10 Million Reasons I'm Not Selling Fulgent Genetics

The company is about to shock Wall Street.

1 month ago - The Motley Fool

Labcorp and 4 Other Stocks Can Boast Value and Momentum

Twice a year in this column, I hunt for stocks that seem to possess both value and momentum. Even though the market has hit records lately, it's still possible to find stocks that have both qualities.

Other symbols:LHAMKRNUESEB
1 month ago - GuruFocus

New Strong Sell Stocks for August 17th

ACCD, CHRS, ELVT, FLGT, and GSHD have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2021.

Other symbols:ACCDCHRSELVTGSHD
1 month ago - Zacks Investment Research

2 Types of Growth Stocks Investors Should Be Holding in Their Portfolios Today

Hedging against COVID-19 could prove to be crucial in keeping your portfolio safe.

Other symbols:ABC
2 months ago - The Motley Fool

Why Shares of Fulgent Genetics Are Plunging Today

Spectacular quarterly results were not enough to satisfy investors' appetites.

2 months ago - The Motley Fool

Fulgent Genetics Stock Falls As Q2 Earnings Miss Street Estimates; Lowers FY21 Sales Outlook

Fulgent Genetics Inc (NASDAQ: FLGT) reported after the close of the market on Monday that its second-quarter revenues increased nearly ninefold, driven primarily by increased test volumes. Revenues skyr...

2 months ago - Benzinga

FULGENT GENETIC (FLGT) Q2 Earnings and Revenues Miss Estimates

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of -0.78% and -21.06%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Fulgent Genetics Reports Second Quarter Financial Results

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology-based genetic testing company focused on transforming patient care in onc...

2 months ago - Business Wire

Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests

TEMPLE CITY, Calif. & IRVINE, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming pa...

2 months ago - Business Wire

Fulgent Genetics Announces Acquisition of CSI Laboratories

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in onc...

2 months ago - Business Wire

FULGENT GENETIC (FLGT) Gains But Lags Market: What You Should Know

In the latest trading session, FULGENT GENETIC (FLGT) closed at $110.87, marking a +0.33% move from the previous day.

2 months ago - Zacks Investment Research

What's in Store for Fulgent Genetics (FLGT) in Q2 Earnings?

Fulgent Genetics' (FLGT) Q2 results are likely to reflect growth in areas like adult neurogenetics, hereditary cancer, hereditary cardiovascular genetics, reproductive health and sequencing as a service.

2 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) Reports Next Week: Wall Street Expects Earnings Growth

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) Gains As Market Dips: What You Should Know

In the latest trading session, FULGENT GENETIC (FLGT) closed at $92.25, marking a +0.36% move from the previous day.

2 months ago - Zacks Investment Research